Diltiazem-associated Photodistributed Hyperpigmentation.
Diltiazem-associated Photodistributed Hyperpigmentation.
Yale J Biol Med. 2020 Mar;93(1):45-47
Authors: Siegel JD, Ko CJ
Abstract
Diltiazem is a calcium-channel blocker commonly used for the treatment of hypertension. Common adverse effects include dizziness, headache, and edema. Fewer than 20 cases of diltiazem-associated photodistributed hyperpigmentation have been reported in the literature. Here, we present the case of a 71-year-old woman with new-onset facial hyperpigmentation 6 months after initiating treatment with diltiazem.
PMID: 32226335 [PubMed - in process]
Source: The Yale Journal of Biology and Medicine - Category: Universities & Medical Training Tags: Yale J Biol Med Source Type: research
More News: Biology | Calcium | Diltiazem | Headache | Hypertension | Migraine | Universities & Medical Training | Yale